Loading provider…
Loading provider…
Hematology & Oncology Physician in Cleveland, OH
NPI: 1093772691Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Bernard's Phone Numberphone_androidMobile
Get M.D. Bernard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 51 | 87 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 38 | 38 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 26 | 33 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Spontaneous perinephric hematoma due to acquired factor X deficiency in AL amyloidosis.
Authors: Vidya Nadig, Robert Heyka
Publication Date: 2010-09-03
A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic.
Authors: Ihab Haddadin, Mehdi Shishehbor, Gustavo Heresi Davila, Marcello Gomes, Maya Serhal
Journal: J Thromb Thrombolysis
Authors: Mikkael Sekeres, Ramon Tiu, Alan Lichtin
Publication Date: 2014-11-14
Lead Sponsor: Baxalta now part of Shire
Collaborators: Baxalta Innovations GmbH, now part of Shire
Intervention / Treatment: BIOLOGICAL: OBIZUR
Lead Sponsor: Bioverativ, a Sanofi company
Intervention / Treatment: DRUG: placebo, DRUG: sutimlimab (BIVV009)
Lead Sponsor: Bioverativ, a Sanofi company
Intervention / Treatment: DRUG: BIVV009